vTv Therapeutics Income Statement (2014-2026) | VTVT

Income Statement Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
1.66M1.67M1.67M1.93M2.04M2.04M2.04M2.04M2.04M2.08M4.14M6.40M5.46M5.77M6.58M6.59M8.06M8.42M12.41M12.41M
Revenue & cost
Revenue (Quarter)
3.00M0.01M2.00M0.01M0.01M1.00M0.02M36.84M
Operating items
Research & Development (Quarter)
2.38M5.40M3.13M2.21M3.06M3.96M3.94M4.69M2.82M2.14M2.65M3.44M3.22M2.23M2.83M4.10M7.02M3.91M8.98M8.77M
Selling, General & Administrative (Quarter)
2.22M5.72M5.35M1.83M2.63M2.39M3.48M3.31M2.54M2.57M3.98M3.72M3.28M2.67M3.67M3.62M3.68M3.98M4.60M5.16M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
4.60M11.12M8.48M4.04M5.69M6.35M7.43M8.00M5.37M4.71M6.63M7.16M6.51M4.91M6.50M7.72M10.70M7.88M13.58M13.93M
Operating Income (Quarter)
-1.60M-11.11M-6.48M-4.03M-5.69M-6.34M-7.43M-8.00M-5.37M-4.71M-5.63M-7.16M-6.51M-4.89M-6.50M-7.72M-10.70M-7.88M23.26M-13.93M
EBIT (Quarter)
-1.60M-11.11M-6.48M-4.03M-5.69M-6.34M-7.43M-8.00M-5.37M-4.71M-5.63M-7.16M-6.51M-4.89M-6.50M-7.72M-10.70M-7.88M23.26M-13.93M
Non-operating items
Interest & Investment Income (Quarter)
0.05M0.15M0.15M0.10M0.15M0.13M0.09M0.08M0.55M0.50M0.43M0.33M0.28M0.40M0.86M0.84M0.81M
Other Non Operating Income (Quarter)
-1.08M0.63M-3.23M0.05M-0.32M-3.84M-0.24M0.30M-3.64M0.17M0.07M0.08M0.00M-0.02M0.05M-0.03M-0.07M0.02M0.04M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-1.36M-9.48M-9.22M-4.09M-5.47M-6.09M-5.77M-7.21M-8.54M-4.44M-5.92M-6.41M-5.84M-4.44M-6.22M-7.38M-10.35M-7.14M24.13M-13.05M
Tax Provisions (Quarter)
0.10M0.20M0.10M
Profit After Tax (Quarter)
-1.09M-9.48M-9.42M-3.15M-4.26M-4.75M-4.50M-5.62M-8.54M1.27M-4.87M-5.18M-5.84M-7.88M-6.22M-7.38M-10.35M-7.14M24.13M-13.05M
Income from Non-Controlling Interests (Quarter)
-0.38M-2.43M-2.42M-0.94M-1.21M-1.34M-1.27M-1.59M-1.89M-0.96M-1.15M-1.23M-1.06M-0.80M-1.12M-1.33M-1.65M
Income from Continuing Operations (Quarter)
-1.47M-9.48M-9.42M-4.09M-5.47M-6.09M-5.77M-7.21M-8.54M-4.44M-6.02M-6.41M-5.84M-4.44M-6.22M-7.38M-10.35M-7.14M24.13M-13.05M
Consolidated Net Income (Quarter)
-1.47M-9.48M-9.42M-4.09M-5.47M-6.09M-5.77M-7.21M-8.54M-4.44M-6.02M-6.41M-5.84M-4.44M-6.22M-7.38M-10.35M-7.14M24.13M-13.05M
Income towards Parent Company (Quarter)
-1.47M-9.48M-9.42M-4.09M-5.47M-6.09M-5.77M-7.21M-8.54M-4.44M-6.02M-6.41M-5.84M-4.44M-6.22M-7.38M-10.35M-7.14M24.13M-13.05M
Net Income towards Common Stockholders (Quarter)
-1.09M-7.05M-7.01M-3.15M-4.26M-4.75M-4.50M-5.62M-6.65M-3.48M-4.87M-5.18M-4.78M-3.63M-5.09M-6.05M-8.70M-7.14M24.13M-13.05M
Additional items
EPS (Basic) (Quarter)
-0.71-4.64-4.19-1.79-2.12-2.53-2.21-2.76-3.27-1.67-1.17-0.81-0.88-0.63-0.77-0.92-1.08-0.851.94-1.05
EPS (Diluted) (Quarter)
-0.71-4.64-4.19-1.79-2.12-2.53-2.21-2.76-3.27-1.67-1.17-0.81-0.88-0.63-0.77-0.92-1.08-0.851.65-1.05
Shares Outstanding (Quarter)
1.53M1.52M1.67M1.76M2.01M1.87M2.04M2.04M2.04M2.08M4.14M6.40M5.46M5.77M6.58M6.59M8.06M8.42M12.41M12.41M
Shares Outstanding (Diluted) (Quarter)
1.53M1.52M1.67M1.76M2.01M1.87M2.04M2.04M2.04M2.08M4.14M6.40M5.46M5.77M6.58M6.59M8.06M8.42M14.63M12.41M
EBITDA (Quarter)
-1.60M-11.11M-6.48M-4.03M-5.69M-6.34M-7.43M-8.00M-5.37M-4.71M-5.63M-7.16M-6.51M-4.89M-6.50M-7.72M-10.70M-7.88M23.26M-13.93M
Interest Expenses (Quarter)
0.89M0.01M0.76M0.70M0.63M0.01M0.47M0.42M0.01M0.32M0.27M0.23M0.00M0.13M0.01M0.20M20.73M17.86M
Tax Rate (Quarter)
-7.33-2.17-1.69